Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|October 23, 2013
PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Trond P Leren
Hematology Reports|August 27, 2025
<i>ANKRD26</i> Gene Mutation and Thrombocytopenia-Is the Risk of Malignancy Dependent on the Mutation Variant?Eirik B Tjønnfjord, Kristian Tveten, Signe Spetalen, et al.
Journal of Lipid Research|March 20, 2013
PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragmentKristian Tveten, Thea Bismo Str M, Knut Erik Berge, et al.
Acta Biochimica Et Biophysica Sinica|March 13, 2009
The effect of bafilomycin A1 and protease inhibitors on the degradation and recycling of a Class 5-mutant LDLRKristian Tveten, Trine Ranheim, Knut Erik Berge, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 11, 2006
Analysis of alternatively spliced isoforms of human LDL receptor mRNAKristian Tveten, Trine Ranheim, Knut Erik Berge, et al.
Atherosclerosis|October 30, 2012
Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemiaKristian Tveten, Thea Bismo Strøm, Jamie Cameron, et al.
Genetic Testing and Molecular Biomarkers|April 18, 2009
Functional analysis of the synonymous R385R mutation in the low-density lipoprotein receptor geneKristian Tveten, Kah-Lin Khoo, Knut Erik Berge, et al.
Biochemical and Biophysical Research Communications|May 3, 2011
The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradationThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Biochemical and Biophysical Research Communications|November 15, 2011
Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Pageof 6